Literature DB >> 27343897

The positive transcriptional elongation factor (P-TEFb) is required for neural crest specification.

Victoria L Hatch1, Marta Marin-Barba1, Simon Moxon1, Christopher T Ford1, Nicole J Ward1, Matthew L Tomlinson1, Ines Desanlis1, Adam E Hendry1, Saartje Hontelez2, Ila van Kruijsbergen2, Gert Jan C Veenstra2, Andrea E Münsterberg1, Grant N Wheeler3.   

Abstract

Regulation of gene expression at the level of transcriptional elongation has been shown to be important in stem cells and tumour cells, but its role in the whole animal is only now being fully explored. Neural crest cells (NCCs) are a multipotent population of cells that migrate during early development from the dorsal neural tube throughout the embryo where they differentiate into a variety of cell types including pigment cells, cranio-facial skeleton and sensory neurons. Specification of NCCs is both spatially and temporally regulated during embryonic development. Here we show that components of the transcriptional elongation regulatory machinery, CDK9 and CYCLINT1 of the P-TEFb complex, are required to regulate neural crest specification. In particular, we show that expression of the proto-oncogene c-Myc and c-Myc responsive genes are affected. Our data suggest that P-TEFb is crucial to drive expression of c-Myc, which acts as a 'gate-keeper' for the correct temporal and spatial development of the neural crest.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cdk9; CyclinT1; Leflunomide; Neural crest cells; P-TEFb; Polymerase pausing; Transcriptional elongation; Xenopus; c-Myc

Mesh:

Substances:

Year:  2016        PMID: 27343897     DOI: 10.1016/j.ydbio.2016.06.012

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

Review 1.  Specifying neural crest cells: From chromatin to morphogens and factors in between.

Authors:  Crystal D Rogers; Shuyi Nie
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2018-05-03       Impact factor: 5.814

2.  The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.

Authors:  Kimberley Hanson; Stephen D Robinson; Karamallah Al-Yousuf; Adam E Hendry; Darren W Sexton; Victoria Sherwood; Grant N Wheeler
Journal:  Oncotarget       Date:  2017-12-17

3.  An efficient miRNA knockout approach using CRISPR-Cas9 in Xenopus.

Authors:  Alice M Godden; Marco Antonaci; Nicole J Ward; Michael van der Lee; Anita Abu-Daya; Matthew Guille; Grant N Wheeler
Journal:  Dev Biol       Date:  2021-12-27       Impact factor: 3.582

4.  The Paf1 complex and P-TEFb have reciprocal and antagonist roles in maintaining multipotent neural crest progenitors.

Authors:  Michael J Jurynec; Xiaoying Bai; Brent W Bisgrove; Haley Jackson; Alex Nechiporuk; Rebecca A S Palu; Hannah A Grunwald; Yi-Chu Su; Kazuyuki Hoshijima; H Joseph Yost; Leonard I Zon; David Jonah Grunwald
Journal:  Development       Date:  2019-12-16       Impact factor: 6.868

5.  Frizzled-7 is required for Xenopus heart development.

Authors:  Muhammad Abu-Elmagd; Joanna Mulvaney; Grant N Wheeler
Journal:  Biol Open       Date:  2017-12-15       Impact factor: 2.422

6.  microRNAs associated with early neural crest development in Xenopus laevis.

Authors:  Nicole J Ward; Darrell Green; Janet Higgins; Tamas Dalmay; Andrea Münsterberg; Simon Moxon; Grant N Wheeler
Journal:  BMC Genomics       Date:  2018-01-18       Impact factor: 3.969

7.  ADAMTS9, a member of the ADAMTS family, in Xenopus development.

Authors:  Ines Desanlis; Hannah L Felstead; Dylan R Edwards; Grant N Wheeler
Journal:  Gene Expr Patterns       Date:  2018-06-21       Impact factor: 1.224

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.